Skip to main content

Vascular Surgery / Drug-Eluting Therapies / Resources / Data Sheets     

 

 

Eluvia™ Drug-Eluting Vascular Stent System

1-year KM Chart primary patency estimate comparing Eluvia at 85.4% and BMS at 76.3%

EMINENT Clinical Trial Data Sheet

View the 1-year results from the world’s largest RCT of SFA stents: Eluvia DES vs. BMS.


Blue chart of KM Estimates Primary Patency rates Eluvia 92.1% and Zilver PTX 81.8%

IMPERIAL 1-Year Data Sheet

View the remarkable results Eluvia DES achieved in the first head-to-head trial: Eluvia DES vs. Zilver PTX.


Blue bar chart of IMPERIAL 2-year results for imperial.

IMPERIAL 2-Year Data Sheet

View 2-year results from the first head-to-head trial: Eluvia DES vs. Zilver PTX.


Chart of 12-month Primary Patency

Münster All-Comers Registry


Line chart of Freedom from TLR: Full Cohort 36 months

MAJESTIC 3-Year Follow-Up Data Sheet

See the unprecedented results of the MAJESTIC trial, which studied stenting of the superficial femoral and/or proximal popliteal artery with the Eluvia Drug-Eluting Stent.

Ranger™ Drug-Coated Balloon

Partial line chart with results circled

COMPARE Clinical Data Sheet

Learn more about the world’s first head-to-head, prospective, multi-center Randomized Controlled Trial (1:1) comparing the lower dose Paclitaxel RANGER DCB (2 µg/mm2) to the higher dose Paclitaxel IN.PACT DCB (3.5 µg/mm2).


Partial view of infographic displaying blue men

RANGER II SFA Pivotal Trial Data Sheet

See how Ranger DCB demonstrated exceptional outcomes at 2-years in the Ranger II SFA Pivotal Trial.

Background image of surgical area and healthcare providers' hands.

Explore DE Resources

Get physician perspectives, clinical data sheets and other resources about drug-eluting innovations.

Background image of healthcare providers' hands using medical equipment.

Stay Up to Date

Receive emails about the latest drug-eluting technology news, innovations and events in your area.

take the fight to pad
Top